Neurovascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices), By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others), By End User (Hospitals, Specialty Clinics, Others), By Region and Competition, 2020-2030F
Market Overview
The Global Neurovascular Devices Market was valued at USD 7.48 Billion in 2024 and is projected to reach USD 10.52 Billion by 2030, growing at a CAGR of 5.82%. This market is expanding rapidly, fueled by the increasing prevalence of neurovascular conditions such as strokes, aneurysms, and arteriovenous malformations. As medical systems prioritize early intervention, there is a growing need for advanced neurovascular technologies that facilitate prompt and minimally invasive treatments. Technological progress in imaging, catheter systems, and stent retrieval methods has significantly enhanced patient outcomes and procedural efficiency. Rising awareness among healthcare professionals and patients regarding the benefits of minimally invasive procedures is also contributing to broader adoption. Additionally, the growing elderly population, which is more prone to neurological ailments, is further driving demand for specialized neurovascular solutions that promote faster recovery and reduce surgical risks.
Key Market Drivers
Rising Incidence of Stroke and Neurovascular Disorders
The increasing frequency of strokes and related neurovascular disorders is a major force behind the market’s growth. Globally, strokes remain a leading cause of mortality and long-term disability, with over 12 million first-time stroke cases reported each year and around 6.5 million resulting in death, according to the World Stroke Organization. A significant proportion of these cases affect individuals under 70, and even a growing number under 50, underscoring the widespread nature of the issue. This surge in neurological conditions has accelerated the demand for prompt, minimally invasive interventions using advanced devices such as thrombectomy catheters, flow diverters, and embolization coils. These tools are essential for quickly restoring cerebral blood flow and reducing damage, ultimately leading to improved recovery outcomes. Furthermore, increased investment in specialized stroke centers and neurointervention capabilities is ensuring broader access to high-performance devices and timely care.
Key Market Challenges
High Cost of Devices and Procedures
The substantial cost associated with neurovascular devices and procedures remains a critical obstacle for the market. Products like stent retrievers, embolization coils, and flow diverters involve complex engineering and premium materials, which contribute to their elevated prices. For example, a Pipeline Embolization Device can cost upwards of USD 27,000, and the comprehensive cost of mechanical thrombectomy per patient often exceeds USD 285,000. These financial demands are compounded by the need for specialized imaging systems, trained professionals, and extended care, further inflating treatment expenses. Access is particularly constrained in low- and middle-income countries, while reimbursement inconsistencies in developed markets can also deter adoption. The financial burden on healthcare systems and patients continues to challenge the broader implementation of advanced neurovascular solutions.
Key Market Trends
Rising Adoption of Artificial Intelligence (AI) and Image-Guided Navigation
A prominent trend shaping the neurovascular devices market is the growing incorporation of Artificial Intelligence (AI) and image-guided navigation technologies. These innovations are enhancing diagnostic and procedural precision by enabling real-time visualization and data-driven decision-making. AI systems assist in the rapid interpretation of complex imaging data, improving detection and treatment planning for conditions such as aneurysms and strokes. Image-guided navigation facilitates safer and more effective placement of devices like stents and catheters by offering detailed vascular mapping. The integration of AI with high-resolution imaging technologies—such as MRI and CT angiography—not only supports personalized treatment strategies but also predicts outcomes and identifies risks before procedures begin. These advancements are streamlining workflows, reducing error rates, and promoting better clinical results, while continued investments in AI-driven platforms are expected to further accelerate innovation and adoption.
Key Market Players
In this report, the Global Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Devices Market.
Available Customizations
Global Neurovascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Global Neurovascular Devices Market was valued at USD 7.48 Billion in 2024 and is projected to reach USD 10.52 Billion by 2030, growing at a CAGR of 5.82%. This market is expanding rapidly, fueled by the increasing prevalence of neurovascular conditions such as strokes, aneurysms, and arteriovenous malformations. As medical systems prioritize early intervention, there is a growing need for advanced neurovascular technologies that facilitate prompt and minimally invasive treatments. Technological progress in imaging, catheter systems, and stent retrieval methods has significantly enhanced patient outcomes and procedural efficiency. Rising awareness among healthcare professionals and patients regarding the benefits of minimally invasive procedures is also contributing to broader adoption. Additionally, the growing elderly population, which is more prone to neurological ailments, is further driving demand for specialized neurovascular solutions that promote faster recovery and reduce surgical risks.
Key Market Drivers
Rising Incidence of Stroke and Neurovascular Disorders
The increasing frequency of strokes and related neurovascular disorders is a major force behind the market’s growth. Globally, strokes remain a leading cause of mortality and long-term disability, with over 12 million first-time stroke cases reported each year and around 6.5 million resulting in death, according to the World Stroke Organization. A significant proportion of these cases affect individuals under 70, and even a growing number under 50, underscoring the widespread nature of the issue. This surge in neurological conditions has accelerated the demand for prompt, minimally invasive interventions using advanced devices such as thrombectomy catheters, flow diverters, and embolization coils. These tools are essential for quickly restoring cerebral blood flow and reducing damage, ultimately leading to improved recovery outcomes. Furthermore, increased investment in specialized stroke centers and neurointervention capabilities is ensuring broader access to high-performance devices and timely care.
Key Market Challenges
High Cost of Devices and Procedures
The substantial cost associated with neurovascular devices and procedures remains a critical obstacle for the market. Products like stent retrievers, embolization coils, and flow diverters involve complex engineering and premium materials, which contribute to their elevated prices. For example, a Pipeline Embolization Device can cost upwards of USD 27,000, and the comprehensive cost of mechanical thrombectomy per patient often exceeds USD 285,000. These financial demands are compounded by the need for specialized imaging systems, trained professionals, and extended care, further inflating treatment expenses. Access is particularly constrained in low- and middle-income countries, while reimbursement inconsistencies in developed markets can also deter adoption. The financial burden on healthcare systems and patients continues to challenge the broader implementation of advanced neurovascular solutions.
Key Market Trends
Rising Adoption of Artificial Intelligence (AI) and Image-Guided Navigation
A prominent trend shaping the neurovascular devices market is the growing incorporation of Artificial Intelligence (AI) and image-guided navigation technologies. These innovations are enhancing diagnostic and procedural precision by enabling real-time visualization and data-driven decision-making. AI systems assist in the rapid interpretation of complex imaging data, improving detection and treatment planning for conditions such as aneurysms and strokes. Image-guided navigation facilitates safer and more effective placement of devices like stents and catheters by offering detailed vascular mapping. The integration of AI with high-resolution imaging technologies—such as MRI and CT angiography—not only supports personalized treatment strategies but also predicts outcomes and identifies risks before procedures begin. These advancements are streamlining workflows, reducing error rates, and promoting better clinical results, while continued investments in AI-driven platforms are expected to further accelerate innovation and adoption.
Key Market Players
- Medtronic plc
- Stryker Corporation
- Terumo Corporation
- Penumbra, Inc.
- Johnson & Johnson Services, Inc.
- Integra LifeSciences Corporation
- Acandis GmbH
- Spiegelberg GmbH & Co. KG
- MicroPort Scientific Corporation
- ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
In this report, the Global Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Neurovascular Devices Market, By Device:
- Cerebral Embolization and Aneurysm Coiling Devices
- Cerebral Angioplasty and Stenting Systems
- Neurothrombectomy Devices
- Support Devices
- Trans Radial Access Devices
- Neurovascular Devices Market, By Therapeutic Application:
- Stroke
- Cerebral Artery
- Cerebral Aneurysm
- Others
- Neurovascular Devices Market, By End User:
- Hospitals
- Specialty Clinics
- Others
- Neurovascular Devices Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Devices Market.
Available Customizations
Global Neurovascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL NEUROVASCULAR DEVICES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices)
5.2.2. By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others)
5.2.3. By End User (Hospitals, Specialty Clinics, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. NORTH AMERICA NEUROVASCULAR DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Device
6.2.2. By Therapeutic Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Neurovascular Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Device
6.3.1.2.2. By Therapeutic Application
6.3.1.2.3. By End User
6.3.2. Mexico Neurovascular Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Device
6.3.2.2.2. By Therapeutic Application
6.3.2.2.3. By End User
6.3.3. Canada Neurovascular Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Device
6.3.3.2.2. By Therapeutic Application
6.3.3.2.3. By End User
7. EUROPE NEUROVASCULAR DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Device
7.2.2. By Therapeutic Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Neurovascular Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Device
7.3.1.2.2. By Therapeutic Application
7.3.1.2.3. By End User
7.3.2. Germany Neurovascular Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Device
7.3.2.2.2. By Therapeutic Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Neurovascular Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Device
7.3.3.2.2. By Therapeutic Application
7.3.3.2.3. By End User
7.3.4. Italy Neurovascular Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Device
7.3.4.2.2. By Therapeutic Application
7.3.4.2.3. By End User
7.3.5. Spain Neurovascular Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Device
7.3.5.2.2. By Therapeutic Application
7.3.5.2.3. By End User
8. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Device
8.2.2. By Therapeutic Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Neurovascular Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Device
8.3.1.2.2. By Therapeutic Application
8.3.1.2.3. By End User
8.3.2. India Neurovascular Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Device
8.3.2.2.2. By Therapeutic Application
8.3.2.2.3. By End User
8.3.3. South Korea Neurovascular Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Device
8.3.3.2.2. By Therapeutic Application
8.3.3.2.3. By End User
8.3.4. Japan Neurovascular Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Device
8.3.4.2.2. By Therapeutic Application
8.3.4.2.3. By End User
8.3.5. Australia Neurovascular Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Device
8.3.5.2.2. By Therapeutic Application
8.3.5.2.3. By End User
9. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Device
9.2.2. By Therapeutic Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Neurovascular Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Device
9.3.1.2.2. By Therapeutic Application
9.3.1.2.3. By End User
9.3.2. Argentina Neurovascular Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Device
9.3.2.2.2. By Therapeutic Application
9.3.2.2.3. By End User
9.3.3. Colombia Neurovascular Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Device
9.3.3.2.2. By Therapeutic Application
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Device
10.2.2. By Therapeutic Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Neurovascular Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Device
10.3.1.2.2. By Therapeutic Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Neurovascular Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Device
10.3.2.2.2. By Therapeutic Application
10.3.2.2.3. By End User
10.3.3. UAE Neurovascular Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Device
10.3.3.2.2. By Therapeutic Application
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. DISRUPTIONS: CONFLICTS, PANDEMICS AND TRADE BARRIERS
14. PORTERS FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Medtronic plc
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Stryker Corporation
15.3. Terumo Corporation
15.4. Penumbra, Inc.
15.5. Johnson & Johnson Services, Inc.
15.6. Integra LifeSciences Corporation
15.7. Acandis GmbH
15.8. Spiegelberg GmbH & Co. KG
15.9. MicroPort Scientific Corporation
15.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL NEUROVASCULAR DEVICES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices)
5.2.2. By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others)
5.2.3. By End User (Hospitals, Specialty Clinics, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. NORTH AMERICA NEUROVASCULAR DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Device
6.2.2. By Therapeutic Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Neurovascular Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Device
6.3.1.2.2. By Therapeutic Application
6.3.1.2.3. By End User
6.3.2. Mexico Neurovascular Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Device
6.3.2.2.2. By Therapeutic Application
6.3.2.2.3. By End User
6.3.3. Canada Neurovascular Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Device
6.3.3.2.2. By Therapeutic Application
6.3.3.2.3. By End User
7. EUROPE NEUROVASCULAR DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Device
7.2.2. By Therapeutic Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Neurovascular Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Device
7.3.1.2.2. By Therapeutic Application
7.3.1.2.3. By End User
7.3.2. Germany Neurovascular Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Device
7.3.2.2.2. By Therapeutic Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Neurovascular Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Device
7.3.3.2.2. By Therapeutic Application
7.3.3.2.3. By End User
7.3.4. Italy Neurovascular Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Device
7.3.4.2.2. By Therapeutic Application
7.3.4.2.3. By End User
7.3.5. Spain Neurovascular Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Device
7.3.5.2.2. By Therapeutic Application
7.3.5.2.3. By End User
8. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Device
8.2.2. By Therapeutic Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Neurovascular Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Device
8.3.1.2.2. By Therapeutic Application
8.3.1.2.3. By End User
8.3.2. India Neurovascular Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Device
8.3.2.2.2. By Therapeutic Application
8.3.2.2.3. By End User
8.3.3. South Korea Neurovascular Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Device
8.3.3.2.2. By Therapeutic Application
8.3.3.2.3. By End User
8.3.4. Japan Neurovascular Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Device
8.3.4.2.2. By Therapeutic Application
8.3.4.2.3. By End User
8.3.5. Australia Neurovascular Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Device
8.3.5.2.2. By Therapeutic Application
8.3.5.2.3. By End User
9. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Device
9.2.2. By Therapeutic Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Neurovascular Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Device
9.3.1.2.2. By Therapeutic Application
9.3.1.2.3. By End User
9.3.2. Argentina Neurovascular Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Device
9.3.2.2.2. By Therapeutic Application
9.3.2.2.3. By End User
9.3.3. Colombia Neurovascular Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Device
9.3.3.2.2. By Therapeutic Application
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Device
10.2.2. By Therapeutic Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Neurovascular Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Device
10.3.1.2.2. By Therapeutic Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Neurovascular Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Device
10.3.2.2.2. By Therapeutic Application
10.3.2.2.3. By End User
10.3.3. UAE Neurovascular Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Device
10.3.3.2.2. By Therapeutic Application
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. DISRUPTIONS: CONFLICTS, PANDEMICS AND TRADE BARRIERS
14. PORTERS FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Medtronic plc
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Stryker Corporation
15.3. Terumo Corporation
15.4. Penumbra, Inc.
15.5. Johnson & Johnson Services, Inc.
15.6. Integra LifeSciences Corporation
15.7. Acandis GmbH
15.8. Spiegelberg GmbH & Co. KG
15.9. MicroPort Scientific Corporation
15.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
